Trial intelligence / Profile preview

Compound Magnolia Flower Nasal Spray in Acute Rhinitis (Wind-Cold Pattern)

CTR20130980Phase 2Active

Start
Nov 2013
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 2 trial of compound magnolia flower nasal spray in nasopharyngitis. Started Nov 2013; status: active.

02

Drugs

compound magnolia flower nasal spray
03

Conditions

nasopharyngitis

Beyond the preview

Go deeper on CTR20130980.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20130980.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call